In 1988, the Alabama Legislature directed the Board of Dental Examiners of Alabama to create a committee to identify, intervene, rehabilitate, and monitor dental professionals facing challenges that may affect safe practice. While originally focused on substance use disorders, the Committee now addresses a broad range of issues, including mental health concerns, physical or emotional impairments, and experiences or instances of abuse.

The Committee, led by Dr. Michael C. Garver, is made up of dedicated dental professionals, often with personal experience in recovery. They volunteer their time to help colleagues acknowledge struggles, access treatment, and return to practice with renewed health and focus.

Dental professionals in need are typically referred by family, friends, or colleagues. Reports may also come from peers or other healthcare professionals, such as pharamacists, physicians, and dental team members. Individuals may self-report and, if eligible, participate in the deferral program with anonymity and other program benefits.

Once referred, individuals may undergo an evaluation at an approved treatment facility, following established protocols that assess physical, psychiatric, psychological, and cognitive health. Facilities specialize in treating healthcare professionals and follow standards set by the Diagnostic and Statistical Manual of Mental Disorders (DSM). Neither the Committee nor the Board receives any benefit from referrals.

Evaluations typically last 3-7 days. If a diagnosis is made, a treatment plan is provided, usually 6-12 weeks in an inpatient or intensive outpatient program. Monitoring and aftercare are critical, and may include abstinence from non-prescribed substances, random drug testing, recovery meeting attendance, and documentation of progress.

If a violation of the Alabama Dental Practice Act is involved, disciplinary action may occur. When recovery is successful, a consent order may allow return to practice with conditions tailored to ensure continued health and safety.

For questions or to seek assistance, contact Committee Chair Dr. Michael Garver at 251-605-2883.
mcg1309@gmail.com